Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein:: application to the study of longitudinal changes throughout normal pregnancy

被引:10
作者
Bertran, N
Camps, J
Fernández-Ballart, J
Murphy, MM
Arija, V
Ferré, N
Tous, M
Joven, J
机构
[1] Hosp Univ St Joan, Ctr Recerca Biomed, Reus 43201, Catalunya, Spain
[2] Univ Rovira & Virgili, Inst Recerca Ciencies Salut, Fac Med & Ciencies Salut, Unitat Med Prevent & Salut Publ, E-43201 Reus, Catalunya, Spain
关键词
C-reactive protein; inflammation; method evaluation; pregnancy;
D O I
10.1515/CCLM.2005.053
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
C-Reactive protein has been associated with several complications of pregnancy. The aims of the present study were: (1) to evaluate a turbidimetric immunoassay for the measurement of C-reactive protein; and (2) to investigate the chronological changes of the levels of this, protein from preconception throughout normal pregnancy and its relationship with variables associated with preconception and pregnancy outcome. Inter-assay imprecision was <5% for C-reactive protein.> 1 mg/L and 18% at a mean value of 0.33 mg/L. The limit of detection was 0.10 mg/L. The method was linear between 0.10 and 30 mg/L. There were no observed interferences from jaundice, hemolysis, lipemia or paraproteinemia at the levels studied. There was good agreement with the nephelometric method. A total of 39 women were studied at preconception, at 8, 20 and 32 weeks of pregnancy, and in labor. Preconception C-reactive protein concentration was 1.17 +/- 0.18 mg/L and increased (p<0.001) throughout pregnancy up to 5.69 +/- 0.82 mg/L. Body mass index at preconception and weight gain during pregnancy were the main factors associated with this increase in C-reactive protein.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 31 条
[1]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[2]
Editorial: Obesity and pregnancy - The propagation of a viscous cycle? [J].
Catalano, PM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08) :3505-3506
[3]
Performance characteristics of an automated high-sensitivity C-reactive protein assay on the Dimension RXL analyzer [J].
De, BK ;
Smith, LG ;
Owen, WE ;
Roberts, WL .
CLINICA CHIMICA ACTA, 2002, 323 (1-2) :151-155
[4]
Impaired vitamin E status in patients with parenchymal liver cirrhosis:: Relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma [J].
Ferré, N ;
Camps, J ;
Prats, E ;
Girona, J ;
Gómez, F ;
Heras, M ;
Simó, JM ;
Ribalta, J ;
Joven, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (05) :609-615
[5]
Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[6]
Hamwi A, 2001, CLIN CHEM, V47, P2044
[7]
C-reactive protein: a serological marker for preterm delivery? [J].
Hvilsom, GB ;
Thorsen, P ;
Jeune, B ;
Bakketeig, LS .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2002, 81 (05) :424-429
[8]
C-reactive protein in uncomplicated parturients delivered by Cesarean section [J].
KeskiNisula, L ;
Kirkinen, P ;
Ollikainen, M ;
Saarikoski, S .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (09) :862-867
[9]
C-reactive protein as a cardiovascular risk factor - More than an epiphenomenon? [J].
Lagrand, WK ;
Visser, CA ;
Hermens, WT ;
Niessen, HWM ;
Verheugt, FWA ;
Wolbink, GJ ;
Hack, CE .
CIRCULATION, 1999, 100 (01) :96-102
[10]
Preanalytic and analytic sources of variations in C-reactive protein measurement: Implications for cardiovascular disease risk assessment [J].
Ledue, TB ;
Rifai, N .
CLINICAL CHEMISTRY, 2003, 49 (08) :1258-1271